Radical surgical resection and high-dose intraoperative radiation therapy (HDR-IORT) in patients with recurrent gynecologic cancers

被引:62
|
作者
Gemignani, ML
Alektiar, KM
Leitao, M
Mychalczak, B
Chi, D
Venkatraman, E
Barakat, RR
Curtin, JP
机构
[1] Mem Sloan Kettering Canc Ctr, Gynecol Serv, Acad Off, Dept Surg, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Biostat & Epidemiol, New York, NY 10021 USA
[4] NYU, Med Ctr, Dept Obstet & Gynaecol, Div Gynecol Oncol, New York, NY USA
关键词
high-dose-rate brachytherapy; IORT; gynecological cancer;
D O I
10.1016/S0360-3016(01)01507-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: To determine the outcome for patients with recurrent gynecologic tumors treated with radical resection and combined high-dose intraoperative radiation therapy (HDR-IORT). Methods and Materials: Between November 1993 and June 1998, 17 patients with recurrent gynecologic malignancies underwent radical surgical resection and high-dose-rate brachytherapy, The mean age of the study group was 49 years (range 28-72 years). The site of the primary tumor was the cervix in 9 (53%) patients, the uterus in 7 (41%) patients, and the vagina in 1 (60%) patient, The treatment for the primary disease was surgery with or without adjuvant radiation in 14 (82%)patients and definitive radiation in 3 (18%) patients, The current surgery consisted of exenterative surgery in 10 (59%) patients and tumor resection in 7 (41%) patients, Complete gross resection was achieved in 13 (76%) patients. The mean HDR-IORT dose was 14 Gy (range 12-15), Additional radiation in the form of permanent Iodine-125 implant was given to 3 of I patients with gross residual disease. The median peripheral dose was 140 Gy. Results: With a median follow-up of 20 months (range 3-65 months), the 3-year actuarial local control (LC) rate was 67%, In patients with complete gross resection, the 3-gear LC rate was 83%, compared to 25% in patients with gross residual disease, p < 0,01, The 3-year distant metastasis disease-free and overall survival rates were 54% and 54%, respectively. The complications were as follows: gastrointestinal obstruction, 4 (24%,); wound complications, 4 (24%); abscesses, 3 (18%); peripheral neuropathy, 3 (18%); rectovaginal fistula, 2 (12%); and ureteral obstruction, 2 (12%). Conclusion: Radical surgical resection and combined IORT for patients with recurrent gynecologic tumors seems to provide a reasonable local-control rate in patients who have failed prior surgery and/or definitive radiation. Patient selection is very important, however, as only those patients with complete gross resection at completion of surgery appear to benefit most from this radical approach in the salvage setting. (C) 2001 Elsevier Science Inc.
引用
收藏
页码:687 / 694
页数:8
相关论文
共 50 条
  • [1] Intensification of local therapy with high-dose rate intraoperative radiation therapy (HDR-IORT) and extended resection for locally advanced and recurrent colorectal cancer
    Agas, Ryan Anthony Francisco
    Tan, Jennifer
    Xie, Sophia
    Van Dyk, Sylvia
    Heriot, Alexander Graham
    Ngan, Samuel Y.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [2] High-dose-rate intraoperative radiation therapy (HDR-IORT) for retroperitoneal sarcomas
    Alektiar, KM
    Hu, K
    Anderson, L
    Brennan, MF
    Harrison, LB
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 47 (01): : 157 - 163
  • [3] Intensification of Local Therapy With High Dose Rate, Intraoperative Radiation Therapy (HDR-IORT) and Extended Resection for Locally Advanced and Recurrent Colorectal Cancer
    Agas, Ryan Anthony F.
    Tan, Jennifer
    Xie, Jing
    Van Dyk, Sylvia
    Kong, Joseph C. H.
    Heriot, Alexander
    Ngan, Samuel Y.
    [J]. CLINICAL COLORECTAL CANCER, 2023, 22 (03) : 257 - 266
  • [4] High dose rate intraoperative radiation therapy (HDR-IORT) as part of the management strategy for locally advanced primary and recurrent rectal cancer
    Harrison, Louis B.
    Minsky, Bruce D.
    Enker, Warren E.
    Mychalczak, Borys
    Guillem, Jose
    Paty, Philip B.
    Anderson, Lowell
    White, Carol
    Cohen, Alfred M.
    [J]. International Journal of Radiation Oncology, Biology, Physics, 42 (02): : 325 - 330
  • [5] High dose rate intraoperative radiation therapy (HDR-IORT) as part of the management strategy for locally advanced primary and recurrent rectal cancer
    Harrison, LB
    Minsky, BD
    Enker, WE
    Mychalczak, B
    Guillem, J
    Paty, PB
    Anderson, L
    White, C
    Cohen, AM
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 42 (02): : 325 - 330
  • [6] Intraoperative Electron Beam Radiation Therapy (IOERT) Versus High-Dose-Rate Intraoperative Brachytherapy (HDR-IORT) in Patients With an R1 Resection for Locally Advanced or Locally Recurrent Rectal Cancer
    Voogt, Eva L. K.
    van Rees, Jan M.
    Hagemans, Jan A. W.
    Rothbarth, Joost
    Nieuwenhuijzen, Grad A. P.
    Cnossen, Jeltsje S.
    Peulen, Heike M. U.
    Dries, Wim J. F.
    Nuyttens, Joost
    Kolkman-Deurloo, Inger-Karine
    Verhoef, Cornelis
    Rutten, Harm J. T.
    Burger, Jacobus W. A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 110 (04): : 1032 - 1043
  • [7] Outcome of patients with local recurrent gynecologic malignancies after resection combined with intraoperative radiation (IORT)
    Arians, N.
    Foerster, R.
    Uhl, M.
    Debus, J.
    Lindel, K.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2015, 191 : S43 - S43
  • [8] High dose rate intra-operative radiation therapy (HDR-IORT) for locally advanced/unresectable primary and locally recurrent rectal cancer
    Harrison, LB
    Minsky, BD
    Enker, WE
    Mychalczak, B
    Guillem, JG
    Paty, P
    Anderson, L
    Cohen, AM
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 39 (02): : 168 - 168
  • [9] Rationale for integrating high-dose rate intraoperative radiation (HDR-IORT) and postoperative external beam radiation with subcutaneous amifostine for the management of stage III/IV head and neck cancer
    Hu, K
    Ship, JA
    Harrison, LB
    [J]. SEMINARS IN ONCOLOGY, 2003, 30 (06) : 40 - 48
  • [10] High-dose-rate (HDR) Intraoperative Brachytherapy and Radical Surgical Resection in the Management of Recurrent Head-and-Neck Cancer
    Scala, L.
    Teckie, S.
    Ho, F.
    Chiu, J.
    Cohen, G.
    Wong, R.
    Ganly, I.
    Wolden, S.
    Zelefsky, M.
    Lee, N.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S150 - S150